Assessing the eligibility of a breast cancer patient for genomic testing | Dr Joseph Gligorov at Annual Meeting 2015 - 101271

Spotlight
Video

Assessing the eligibility of a breast cancer patient for genomic testing | Dr Joseph Gligorov at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: Genomic tests, such as the Oncotype DX® Breast Cancer Assay, provide results that quantify recurrence risk and identify patients who are likely or unlikely to benefit from adjuvant chemotherapy. At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, outlines the approaches for effectively communicating personalised genomic disease-risk information to breast cancer patients.

This content is supported by Genomic Health, Inc.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 09/17/15
Added : 4 years ago
Category : Breast Cancer